Nutritionists recommend blue maize extract as a safe natural alternative to prevent metabolic syndrome

(Natural News) Metabolic syndrome is a serious and dangerous health issue. A particular study published in the Journal of Medicinal Food discusses how the extract of blue maize, a variety of corn grown in Mexico and the Southwestern United States, can help attenuate the condition’s symptoms. A person with metabolic syndrome suffers from several metabolic...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news

Related Links:

In a recent study, scientists have investigated the impact of the environment where we live on the risk of developing hypertension and metabolic syndrome.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Hypertension Source Type: news
AbstractBackgroundPrevious studies reported an inverted relationship between nut consumption and the incidence of metabolic syndrome (MetS). The present study investigated the incidental risk for MetS according to peanut, almond, and fine nut consumption in the Korean population.MethodsIn a community-based Korean cohort, 5306 Korean adults were divided into four groups according to their peanut, almond, and fine nut intake (
Source: Endocrine - Category: Endocrinology Source Type: research
Epidemiological data suggest an increased risk of developing Alzheimer’s disease (AD) in individuals with type 2 diabetes (T2D). AD is anatomically associated with an early progressive accumulation of A leading to a gradual Tau hyperphosphorylation, which constitute the main characteristics of damaged brain in AD. Apart from these processes, mounting evidence suggests that specific features of diabetes, namely impaired glucose metabolism and insulin signaling in the brain, play a key role in AD. Moreover, several studies report a potential role of A and Tau in peripheral tissues such as pancreatic cells. ...
Source: Frontiers in Neurology - Category: Neurology Source Type: research
Conclusions: In general, the measures of adiposity have sufficient diagnostic accuracy to be utilized as the screening tool for increased cardiometabolic risk. The observed cut-points for adiposity were lower than the traditional cut-points for adiposity.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
CONCLUSIONS: MHO increased the prevalence of carotid plaque when compared with non-obese subjects, suggesting the potential significance of MHO in the development of subsequent cardiovascular diseases. PMID: 31231080 [PubMed - as supplied by publisher]
Source: Journal of Atherosclerosis and Thrombosis - Category: Cardiology Tags: J Atheroscler Thromb Source Type: research
Publication date: Available online 24 June 2019Source: Trends in Endocrinology &MetabolismAuthor(s): Jo E. Lewis, Francis J.P. Ebling, Ricardo J. Samms, Kostas TsintzasFibroblast growth factor 21 (FGF21) is a protein highly synthesized in the liver that exerts paracrine and endocrine control of many aspects of energy homeostasis in multiple tissues. In preclinical models of obesity and type 2 diabetes, treatment with FGF21 improves glucose homeostasis and promotes weight loss, and, as a result, FGF21 has attracted considerable attention as a therapeutic agent for the treatment of metabolic syndrome in humans. An improv...
Source: Trends in Endocrinology and Metabolism - Category: Endocrinology Source Type: research
Funding Opportunity PAR-19-304 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Exploratory/Developmental Phase II (R33) grant applications to facilitate early-stage T1 translation (bench-to-bedside) of discoveries from basic and applied research in aging into novel therapeutics for the prevention and treatment of clinical conditions related to aging or multiple chronic conditions in older people (e.g., sarcopenia, hearth failure with preserved ejection fraction (HFePF), immunosenescence, pulmonary fibrosis, metabolic syndrome, chronic kidney disease). This includes the d...
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding
Funding Opportunity PAR-19-305 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Exploratory/Developmental Phased Innovation (R21/R33) grant applications to facilitate early-stage T1 translation (bench-to-bedside) of discoveries from basic and applied research in aging into novel therapeutics for the prevention and treatment of clinical conditions related to aging and/or multiple chronic conditions in older people (e.g., sarcopenia, heart failure with preserved ejection fraction (HFpEF), immunosenescence, metabolic syndrome, chronic kidney disease). This includes the devel...
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding
Recent studies have suggested that neck circumference (NC) is a supplemental screening measure for diagnosing metabolic complications and might be associated with glycemic parameters. The aim of the present st...
Source: Diabetology and Metabolic Syndrome - Category: Endocrinology Authors: Tags: Review Source Type: research
Publication date: Available online 30 May 2019Source: Journal of Clinical and Experimental HepatologyAuthor(s): Narendra S. Choudhary, Sanjiv SaigalPost-transplant nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH) is common and can be recurrent or de novo. The available data suggest that progression of fibrosis is accelerated in these patients compared to NASH in general population. The long-term data suggest more risk of metabolic syndrome and associated metabolic comorbidities and cardiovascular disease in these patients. The current review focuses on prevalence and prevention...
Source: Journal of Clinical and Experimental Hepatology - Category: Gastroenterology Source Type: research
More News: Metabolic Syndrome | Mexico Health | Nutrition | Study | USA Health